Results 101 to 110 of about 4,446,831 (170)

Hearing Loss in Systemic Lupus Erythematosus: a Systematic Review. [PDF]

Maedica (Bucur)
Hanna Y, Tlais M, Natour D, Mazraani Y, Obeid N, Sarraf G, Zalzali I, Moghnie Y, Harouny T, Chebbo H, Farhat H.   +10 more
europepmc   +1 more source

Breaking barriers in extensively drug-resistant TB: pretomanid-centred long regimen achieves cure in a bedaquiline-resistant strain. [PDF]

IJTLD Open
Schiuma M, Piubello A, Saluzzo F, Cattaneo D, Salari F, Covizzi A, Rizzo A, Fama F, Ciubotariu C, Lombardi A, Antinori S, Riva A, Cirillo DM, Gori A, Torre A.   +14 more
europepmc   +1 more source

Pharmacogenetic strategies to mitigate cisplatin-induced ototoxicity in head and neck cancer: A cost-minimization analysis with the use of GSTP1 c.313A>G genotyping. [PDF]

PLoS One
Macedo LT, Ferrari VE, Dias Costa EF, Lourenço GJ, Calonga L, Castilho AM, Chone CT, Passos Lima CS.   +7 more
europepmc   +1 more source

Rate of Hearing Loss in Platinum-Naïve Patients Receiving Immune Checkpoint Inhibitors. [PDF]

Otolaryngol Head Neck Surg
Brooks KA, Gidley CG, Grimley O, Wang C, Jivani S, Roberts D, Naing A, Phan J, Hutcheson K, Wang X, Gidley PW, Nader ME.   +11 more
europepmc   +1 more source

Hearing Characteristics of Adults before Exposure to Potentially Ototoxic Chemotherapy. [PDF]

Int Arch Otorhinolaryngol
Peruch CV, Martins VB, Goulart FO, Machado MS, Dallegrave E, Berbert MCB.   +5 more
europepmc   +1 more source

Targeting ferroptosis in sensorineural hearing loss: mechanisms, therapeutics, and translational prospects. [PDF]

Front Neurol
Zhang L, Luo P, Liu X, Guo T, Xie H.
europepmc   +1 more source

Rediscovering the Gut-Mito-Ear Axis: A Systems-Biology Framework for Ototoxic Vulnerability and Microbiome-Targeted Prevention. [PDF]

Cells
Yim CD, Kwon H, Park JJ, Lee SJ, Seo JH, Hah YS, Ahn SK.   +6 more
europepmc   +1 more source

From Ototoxicity to Otoprotection: Mechanism and Protective Strategies in Cisplatin Therapy. [PDF]

Pharmaceuticals (Basel)
Iațentiuc A, Cozma SR, Frăsinariu OE, Miron IC, Iațentiuc IM, Dima-Cozma LC, Olariu R, Postolache A, Buga AL, Stingheriu A, Boéchat E, Bitere-Popa OR.   +11 more
europepmc   +1 more source

Impact of cisplatin dose, renal function, and other factors on audiometrically-assessed ototoxicity in more than 1400 adult-onset cancer survivors from The Platinum Study: a multicentre cohort study. [PDF]

EClinicalMedicine
Sanchez VA, Dinh PC, Monahan PO, Fung C, Althouse S, Stump T, Rooker J, Dolan ME, Feldman DR, Hamilton RJ, Pierorazio PM, Martin NE, Huddart R, Kollmannsberger C, Root J, Sesso HD, Weinzierl M, Einhorn LH, Frisina RD, Travis LB.   +19 more
europepmc   +1 more source

Monitoring Ototoxicity with DPOAEs

, 2016
openaire   +1 more source